News about Global Pharma

Phanes Secures Fast Track Designation for PT217 from FDA

PT217, a first-in-class native IgG-like bispecific antibody (bsAb) targeting DLL3 and CD47, is being developed for the treatment of patients with small cell lung cancer (SCLC) and neuroendocrine carcinoma, including neuroendocrine prostate cancer (NEPC).

Global Pharma | 05/12/2024 | By Aishwarya |  376

Orbit Discovery, Evergreen Theragnostics Expand Research Alliance to Boost Targeted Therapeutics Development

The expanded collaboration will leverage Orbit Discovery’s proprietary screening platform to identify and optimize peptide candidates, combined with Evergreen Theragnostics’ expertise in radiopharmaceutical development and clinical translation.

Global Pharma | 04/12/2024 | By Aishwarya |  316

Martin Pharmaceuticals Gets Exclusive Rights from MTPC for Docarpamine

The Phase 2a open-label trial enrolled 16 patients with refractory ascites requiring regular large-volume paracentesis (LVP).

Global Pharma | 04/12/2024 | By Aishwarya |  499

Ampersand Capital Partners Launches Newly Branded Business Gannet BioChem

The new Ampersand portfolio company will be branded Gannet BioChem and will continue to operate out of its state-of-the-art facility in Huntsville, Alabama.

Global Pharma | 03/12/2024 | By Aishwarya |  828

CBC Group Acquires UCB's Mature Product Portfolio in China

The acquisition marks another successful transaction under CBC's buyout strategy of acquiring key assets from global pharmaceutical companies and a significant step in establishing a market-leading neurology company in China while expanding CBC's portfolio within the region's dynamic pharmaceutical market.

Global Pharma | 03/12/2024 | By Aishwarya |  689

Roche Announces Acquisition of Poseida Therapeutics

The proposed acquisition will establish a new core capability for Roche in allogeneic cell therapy, with lead opportunities focused on CAR-T programs covered by the existing strategic collaboration between Poseida and Roche in hematologic malignancies.

Global Pharma | 03/12/2024 | By Aishwarya |  398

Brenntag, K+S to Expand its Business in High-Purity Salts for Pharma Applications

Brenntag will now distribute three of their salts in the pharmaceutical market: APISAL Sodium Chloride GMP grade (in pharmacopoeia quality, API), Potassium Chloride 99.9 percent KCl Ph. Eur., USP (API) and HD-NaCl (excipient grade).

Global Pharma | 03/12/2024 | By Aishwarya |  318

Allink Biotherapeutics Secures USD 42 Million Series A Financing Round

The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.

Global Pharma | 02/12/2024 | By Aishwarya |  220

ASPA Promotes Members' Anti-Counterfeiting Solutions Globally

In his address, Puneet highlighted ASPA's growing global presence and its strategic efforts to fight counterfeiting by promoting the innovative anti-counterfeiting solutions offered by its members internationally.

Global Pharma | 02/12/2024 | By Aishwarya |  589

MGI Tech Partners with Universidad de San Martin de Porres to Boost Human Genetics Research

This advancement will enable the identification of genetic risk factors in the population for the development of future public health treatments.

Global Pharma | 02/12/2024 | By Aishwarya |  294